SECTRA (SECT) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
4 Sep, 2025Executive summary
Order bookings more than doubled year-over-year, driven by strong performance in the US and Canada, primarily through SaaS and major new contracts in medical IT and cybersecurity.
All operating areas reported growth, with significant progress in transitioning to a pay-for-usage SaaS and service-based model.
Customer satisfaction remains high, especially in North America, supporting continued expansion.
Net sales rose 5.8% to SEK 765.9 million, with recurring revenue up 13.9% and cloud recurring revenue up 46.1% year-over-year.
Operating profit increased 19% to SEK 118.8 million, with a margin of 15.5%.
Financial highlights
Contracted order bookings reached SEK 1,309.5 million, up 112.9% year-over-year; guaranteed order bookings were SEK 1,192.3 million, up 119.5%.
Net sales were SEK 765.9 million, up 5.8% (12.1% at unadjusted exchange rates).
Recurring revenue was SEK 549.2 million, up 13.9%; cloud recurring revenue was SEK 179.4 million, up 46.1%.
Operating profit was SEK 118.8 million, up 19.0%; profit for the period was SEK 102.8 million, up 27.9%.
Earnings per share increased 26.2% to SEK 0.53.
Outlook and guidance
Large contracts signed in recent years will begin generating revenue this fiscal year, but full ramp-up will take 2–3 years.
Transition to service and cloud-based sales is expected to drive stable, long-term recurring revenue growth.
Sequential recurring revenue growth is expected to remain gradual as new customers are onboarded incrementally.
Increased investment in resilience and security in NATO countries is anticipated to create long-term opportunities.
Currency exposure remains significant due to a large share of revenue in foreign currencies.
Latest events from SECTRA
- Cloud recurring revenue surged 58% and operating profit rose 21%, led by Imaging IT growth.SECT
Q3 25/266 Mar 2026 - Cloud recurring revenue surged 55.9% and operating profit rose 13.6% year-over-year.SECT
Q4 23/2431 Jan 2026 - Q1 sales up 24%, operating profit up 44%, with strong recurring and cloud revenue growth.SECT
Q1 24/2522 Jan 2026 - Record order intake and recurring revenue growth offset by lower profit during cloud transition.SECT
Q2 24/2511 Jan 2026 - Sales up 13%, cloud recurring revenue up 44%, and profit boosted by a patent settlement.SECT
Q3 24/2521 Dec 2025 - Cloud and recurring revenue growth drive profit, but upfront costs pressure margins.SECT
Q2 25/2612 Dec 2025 - SaaS, AI, and integrated diagnostics drive global growth and leadership in medical IT.SECT
CMD 20251 Dec 2025 - Record order intake and recurring revenue growth drive profitability and cash flow.SECT
Q4 24/2511 Nov 2025